Interleukin-15 as a potential costimulatory cytokine in CD154 gene therapy of chronic lymphocytic leukemia

被引：15

作者：

Anether, G

Marschitz, I

Tinhofer, I

Greil, R ^{[1
]}

机构：

[1] Univ Innsbruck, Lab Mol Cytol, A-6020 Innsbruck, Austria

[2] Univ Innsbruck, Tyrolean Canc Res Inst, A-6020 Innsbruck, Austria

来源：

BLOOD | 2002年 / 99卷 / 02期

关键词：

D O I：

10.1182/blood.V99.2.722

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：722 / 723

页数：2

共 6 条

[1] Acquired CD40-ligand deficiency in chronic lymphocytic leukemia [J].

Cantwell, M ;

Hua, T ;

Pappas, J ;

Kipps, TJ .

NATURE MEDICINE, 1997, 3 (09) :984-989

[2] MECHANISM AND BIOLOGICAL SIGNIFICANCE OF CD4-MEDIATED CYTOTOXICITY [J].

HAHN, S ;

GEHRI, R ;

ERB, P .

IMMUNOLOGICAL REVIEWS, 1995, 146 :57-79

[3] Differential sensitivity of CD4+ and CD8+ T lymphocytes to the killing efficacy of Fas (Apo-1/CD95) ligand+ tumor cells in B chronic lymphocytic leukemia [J].

Tinhofer, I ;

Marschitz, I ;

Kos, M ;

Henn, T ;

Egle, A ;

Villunger, A ;

Greil, R .

BLOOD, 1998, 91 (11) :4273-4281

[4] Interleukin-15 promotes the growth of leukemic cells of patients with B-cell chronic lymphoproliferative disorders [J].

Trentin, L ;

Cerutti, A ;

Zambello, R ;

Sancetta, R ;

Tassinari, C ;

Facco, M ;

Adami, F ;

Rodeghiero, F ;

Agostini, C ;

Semenzato, G .

BLOOD, 1996, 87 (08) :3327-3335

[5]

Wierda WG, 2000, BLOOD, V96, P2917

[6]

Zheng Z, 1998, J EXP CLIN CANC RES, V17, P251

← 1 →